Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies

16 Sept 2017

Abstract excerpt

// Jun Li 1, 2, * , Priyank Kumar 1, * , Nagaraju Anreddy 1 , Yun-Kai Zhang 1 , Yi-Jun Wang 1 , Yanglu Chen 1, 3 , Tanaji T. Talele 1 , Kanav Gupta 1, 4 , Louis D. Trombetta 1 and Zhe-Sheng Chen 1 1 Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, New York, 11439, USA 2 Department of Otolaryngology-Head and Neck Surgery, Zhongnan Hospital of Wuhan...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Transport and Resistance Mechanisms
Share to HIV/AIDS drug development and treatment
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29212189
DOI: 10.18632/oncotarget.21078

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studiesPMID 29212189Read ↗

Quizartinib: a new hope in acute myeloid leukemia, an applied comprehensive review.Semantic proximity Read ↗

Afatinib circumvents multidrug resistance via dually inhibiting ATP binding cassette subfamily G member 2 in vitro and in vivoSemantic proximity Read ↗

Bafetinib (INNO-406) reverses multidrug resistance by inhibiting the efflux function of ABCB1 and ABCG2 transporters.Semantic proximity Read ↗

A Novel Two Mode-Acting Inhibitor of ABCG2-Mediated Multidrug Transport and Resistance in Cancer ChemotherapySemantic proximity Read ↗

Quizartinib: a potent and selective FLT3 inhibitor for the treatment of patients with FLT3-ITD-positive AML.Semantic proximity Read ↗

Molecular pharmacology of ABCG2 and its role in chemoresistance.Semantic proximity Read ↗

ABC Transporter Inhibitors in Reversing Multidrug Resistance to ChemotherapySemantic proximity Read ↗

Dynamic vs Static ABCG2 Inhibitors to Sensitize Drug Resistant Cancer CellsSemantic proximity Read ↗

The role of quizartinib in the treatment of acute myeloid leukemia.Semantic proximity Read ↗

Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug ResistanceSemantic proximity Read ↗

Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivoSemantic proximity Read ↗

Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) InhibitorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.